Treatment to Prevent Hepatitis B Virus Reactivation in Patients With Lymphoma Receiving Chemotherapy

被引：2
|
作者：
Baang, Jihoon [1 ]
机构：
[1] Temple Univ, Dept Med, Sch Med, Philadelphia, PA 19140 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 12期
关键词：
RESISTANCE; LAMIVUDINE; ENTECAVIR;
D O I：
10.1001/jama.2015.1438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 50 条
  • [1] Treatment to Prevent Hepatitis B Virus Reactivation in Patients With Lymphoma Receiving Chemotherapy Reply
    Lin, Tongyu
    Huang, He
    Li, Xueying
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (12): : 1270 - 1270
  • [2] Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy
    Ikeda, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (01) : 8 - 16
  • [3] Hepatitis B Reactivation in Patients Receiving Chemotherapy for Lymphoma or Breast Cancer
    Saumoy, Monica
    Schneider, Yecheskel
    Schwartz, Robert
    Kumar, Sonal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S907 - S907
  • [4] Evidence of reactivation of hepatitis B virus in patients receiving chemotherapy for malignancies
    Ikeda, Masafumi
    Takahashi, Hideaki
    Hashimoto, Yusuke
    Ohno, Izumi
    Mitsunaga, Shuichi
    Umemoto, Kumiko
    Watanabe, Kazuo
    Okusaka, Takuji
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy
    Hsu, Chiun
    Wei, Shu-Chen
    Cheng, Ann-Lii
    Chen, Pei-Jer
    HEPATOLOGY, 2009, 50 (02) : 654 - 655
  • [6] Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: Role of lamivudine prophylaxis
    Coiffier, Bertrand
    CANCER INVESTIGATION, 2006, 24 (05) : 548 - 552
  • [7] Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy
    Su, Yi-Chia
    Lin, Pei-Chin
    Yu, Hsien-Chung
    Wu, Chih-Chien
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (08) : 925 - 929
  • [8] Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
    Oketani, Makoto
    Ido, Akio
    Uto, Hirofumi
    Tsubouchi, Hirohito
    HEPATOLOGY RESEARCH, 2012, 42 (07) : 627 - 636
  • [9] Impact of routine screening and preemptive treatment on hepatitis B virus reactivation (HBVr) in patients receiving chemotherapy
    Marty, C.
    Martel, D.
    Martel-Lafernere, V.
    Doucet, S.
    Ceballos, P.
    Adam, J-P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] COST-EFFECTIVENESS ANALYSIS OF HEPATITIS B VIRUS SCREENING TO PREVENT HEPATITIS B VIRUS REACTIVATION IN PATIENTS RECEIVING RITUXIMAB BASED CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCY
    Buti, M.
    Crespo, J.
    Esteban, R.
    Torres, C.
    Oyaguez, I.
    Casado, M. A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S596 - S596
12345